[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351294-105":59,"doc-detail-351294-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","coagulation-factor-ii-receptor-like-1-as-a-prognostic-and-immuno-modulatory-factor-in-head-and-neck-squamous-cell-carcinoma","Coagulation factor II receptor-like 1 as a prognostic and immuno-modulatory factor in head and neck squamous cell carcinoma","","Head and neck squamous cell carcinoma (HNSCC) is a leading cause of cancer mortality and requires reliable biomarkers for prognosis and immuno-oncology research. The study evaluates coagulation factor II receptor-like 1 (F2RL1) by analyzing TCGA-HNSC RNA-seq data and clinical follow-up, with three GEO cohorts for external confirmation. Immune infiltration, functional enrichment, and multi-omics annotations are integrated, and experimental validation uses RT-qPCR, western blotting, and immunohistochemistry to link F2RL1 with immune-related features.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/coagulation-factor-ii-receptor-like-1-as-a-prognostic-and-immuno-modulatory-factor-in-head-and-neck-squamous-cell-carcinoma/351294/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/coagulation-factor-ii-receptor-like-1-as-a-prognostic-and-immuno-modulatory-factor-in-head-and-neck-squamous-cell-carcinoma/351294.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What disease is the study focused on?","Question",{"text":112,"@type":113},"The study focuses on head and neck squamous cell carcinoma (HNSCC).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is F2RL1 and why is it investigated in this research?",{"text":117,"@type":113},"F2RL1 is described as a coagulation factor II receptor-like protein involved in inflammation, pain-related processes, and cancer development, making it a candidate biomarker and therapeutic target in HNSCC.",{"name":119,"@type":110,"acceptedAnswer":120},"How was F2RL1 assessed across datasets and models?",{"text":121,"@type":113},"F2RL1 expression and associations were analyzed using TCGA-HNSC and externally confirmed in three GEO cohorts, alongside immune infiltration and functional/multi-omics analyses. Experimental validation included RT-qPCR, western blotting, and immunohistochemistry (IHC).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351294,1790181886,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Submitted 24 October 2024 Accepted 31 January 2026 Published 18 March 2026  \nCorresponding authors Lu Zhang, [zl1991xr@163.com](zl1991xr@163.com)[ ](zl1991xr@163.com)Xuewei Zhuang, [zxw15288869381@163.com](zxw15288869381@163.com)  \nAcademic editor Hilal Ozdag  \nAdditional Information and Declarations can be found on page 20  \nDOI 10.7717/peerj.20970  \n Copyright 2026 Dai et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nOPEN ACCESS  \nCoagulation factor II receptor-like 1 asa prognostic and immuno-modulatory factor in head and neck squamous cell carcinoma  \nYong gang Dai1 , Shiliang Cheng1 , Wei Wang2 , Hongya Wang1 , Lu Zhang1 and Xuewei Zhuang1  \n1 Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan City, Shandong Province, China  \n2 Department of Clinical Microbiology Laboratory, Shandong Second Provincial General Hospital, Jinan City, Shandong Province, China  \nABSTRACT  \nBackground. Head and neck squamous cell carcinoma (HNSCC) remains a major cause of cancer mortality, and robust biomarkers are needed for prognosis stratification and immuno-oncology research. We investigated coagulation factor II receptorlike 1 (F2RL1) in HNSCC, focusing on expression, clinical outcomes and immune associations.  \nMethods. RNA sequencing and clinical follow-up data from The Cancer Genome Atlas head and neck squamous cell carcinoma cohort (TCGA-HNSC) were analysed. Three independent Gene Expression Omnibus (GEO) cohorts (GSE9844, GSE55547 and GSE55548) were used for external confirmation, with preprocessing and differentialexpression exports generated using Xiantao Academic. Immune infiltration, functional enrichment and multi-omics annotations were assessed. Experimental validation was performed using reverse transcription quantitative polymerase chain reaction (RTqPCR), western blotting and immunohistochemistry (IHC) .  \nResults. F2RL1 was significantly upregulated in HNSCC and was associated with worse overall survival (OS) . Expression differences were consistent across the three GEO cohorts. F2RL1 showed significant associations with immune cell infiltration and immune checkpoint genes, and correlated with DNA methylation features and N6-methyladenosine (m6A) regulators. A nomogram was constructed to estimate 1-, 3-and 5-year OS.  \nConclusion. F2RL1 is reproducibly overexpressed in HNSCC and is linked to adverse outcomes and immune-related features, supporting its potential as a prognostic biomarker and candidate therapeutic target.  \nSubjects Allergy and Clinical Immunology, Oncology  \nKeywords Head and neck squamous cell carcinoma, F2RL1, Immune infiltration, N6-methyladenosine, Prognosis  \nINTRODUCTION  \nHead and necksquamous cell carcinoma (HNSCC) refers toa range of tumors that originate from the mucosal layers of the upper respiratory and digestive tracts, encompassing tumors  \nHow to cite this article Dai Y, Cheng S, Wang W, Wang H, Zhang L, Zhuang X. 2026. Coagulation factor II receptor-like 1 as a prognostic and immuno-modulatory factor in head and neck squamous cell carcinoma. PeerJ 14:e20970 [http://doi.org/10.7717/peerj.20970](http://doi.org/10.7717/peerj.20970)  \nin the mouth, pharyngeum, and larynx. Worldwide, the incidence of HNSCC exceeds 650,000 annual instances, resulting in over 330,000 deaths, positioning it as the sixth most prevalent cancer and the seventh most cause of cancer-related fatalities (Johnson et al., 2020) . Despite advancements in surgeries, radiotherapeutic methods, and cancer therapies, the five-year survival rate remains only about 50%, suggesting minimal advancements in recent years (Siegel et al., 2023) . This highlights the critical need for innovative diagnostic markers and treatment options, especially for those struggling with persistent or metastatic diseases (Chung & Gillison, 2009) .  \nThe protein-activated receptor 2 (PAR2), known as coagulation factor II receptorlike 1 (F2RL1), is crucially involved in numerous biological and patholog","cbCaidiXLJiWanx5","https://ap.wps.com/l/cbCaidiXLJiWanx5","pdf",22042521,24,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Disease background and need for biomarkers\n## Biological rationale for F2RL1 in HNSCC\n## Study objectives and approach","[{\"question\":\"What disease is the study focused on?\",\"answer\":\"The study focuses on head and neck squamous cell carcinoma (HNSCC).\"},{\"question\":\"What is F2RL1 and why is it investigated in this research?\",\"answer\":\"F2RL1 is described as a coagulation factor II receptor-like protein involved in inflammation, pain-related processes, and cancer development, making it a candidate biomarker and therapeutic target in HNSCC.\"},{\"question\":\"How was F2RL1 assessed across datasets and models?\",\"answer\":\"F2RL1 expression and associations were analyzed using TCGA-HNSC and externally confirmed in three GEO cohorts, alongside immune infiltration and functional/multi-omics analyses. Experimental validation included RT-qPCR, western blotting, and immunohistochemistry (IHC).\"}]","Coagulation factor II receptor-like 1 as a prognostic and immuno-modulatory factor in head and neck squamous cell carcinoma | PDF",1790093428,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/522f9bc75ddaa5bf273a831513215478.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ac59972275a3e8944f8eb709f6e75a8.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcb48daf0586e0f1b0b2a997705eb3f2.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e712462bf5ee33851bee4202999e8d5.webp",980,1268]